Physician profile

Matthew Lemer

White Plains, NY

NPI 1598717589

$9,576.04

in general payments reported to CMS, 2019-2025

37 companies · $2,310 in 2025

The $2,310 reported for 2025 was more than what 95% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,566.54

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Endo Pharmaceuticals INC. $1,196.89 2019-2024 Xiaflex, Aveed, Edex
Teleflex LLC $1,115.37 2021-2025 Urolift, Barrigel
Astellas Pharma US INC $1,022.51 2019-2024 Myrbetriq, Xtandi
Pfizer INC. $658.94 2019-2025
Endo USA, INC. $547.41 2024-2025 Xiaflex, Aveed, Edex
Abbvie INC. $510.36 2019-2025
Antares Pharma, INC. $474.89 2022-2025 Xyosted, Nocdurna, Tlando
Immunitybio, INC. $389.79 2024-2025
Ferring Pharmaceuticals INC. $383.91 2019-2025 Adstiladrin
Bayer Healthcare Pharmaceuticals INC. $367.60 2022-2025
Janssen Biotech, INC. $355.54 2019-2025 Erleada, Balversa, Akeega
Allergan, INC. $340.41 2019-2022
Merck Sharp & Dohme LLC $310.04 2020-2025 Lynparza, Keytruda
Urogen Pharma, INC. $299.16 2025
Tolmar, INC. $189.25 2024-2025 Jatenzo
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Myriad Genetic Laboratories, INC. $180.15 2021-2024 Prolaris, Myrisk
Dendreon Pharmaceuticals LLC $164.74 2020-2025 Provenge
Myovant Sciences INC. $121.65 2022
Progenics Pharmaceuticals, INC. $89.31 2021-2025
Coloplast Corp $89.28 2019-2025
180 Medical, INC. $78.25 2019-2020
Acerus Pharmaceuticals Corporation $77.62 2021-2022
Dentsply Ih Ab $74.48 2024-2025 Lofric
Sumitomo Pharma America, INC. $70.34 2023 Orgovyx
Amgen INC. $61.85 2022-2023 Xgeva
Urovant Sciences INC $54.44 2021-2022
Olympus America INC. $50.74 2024-2025 Itind System
Hollister Incorporated $46.25 2020-2022
Accord Healthcare, INC. $45.88 2023-2024
Blue Earth Diagnostics $40.52 2021-2023
Halozyme INC $36.10 2023
Aytu Biopharma, INC. $31.21 2019-2020
Dentsply Ih INC. $27.99 2019
Verity Pharmaceuticals INC. $21.93 2024 Trelstar
Axonics, INC. $19.64 2021
C. R. Bard, INC. & Subsidiaries $15.83 2019
Boston Scientific Corporation $15.77 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Matthew Lemer

$9,576.04

in general payments reported 2019-2025

Years
2019-2025
Top company
Endo Pharmaceuticals INC.
Context
The $2,310 reported for 2025 was more than what 95% of providers received nationally.

https://glasscript.com/doctor/1292022/matthew-lemer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.